Back

Notification report


General information

Notification Number
B/ES/10/38

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
11/02/2010

Title of the Project
Notification for the deliberate release of genetically modified DAS-59122-7 maize (4-year program 2010 to 2013).

Proposed period of release:
01/04/2010 to 31/12/2010

Name of the Institute(s) or Company(ies)
PIONEER HI-BRED AGRO SERVICIOS SPAIN S.L., Avenida Reino Unido, s/n
Edificios ADYTEC – Euroficinas, 2nda planta
41012 Sevilla;


3. Is the same GMPt release planned elsewhere in the Community?
No

Has the same GMPt been notified elsewhere by the same notifier?
No

Genetically modified plant

Complete name of the recipient or parental plant(s)
Common NameFamily NameGenusSpeciesSubspeciesCultivar/breeding line
maizepoaceaezeazea maysmays

2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:
New genes were introduced into the genetically modified DAS-59122-7 maize (referred to as 59122 maize) so that it can fight against the damages caused by certain Coleopteran insect pests, such as Western corn rootworm (Diabrotica virgifera virgifera). Tolerance to glufosinate-ammonium herbicide has been introduced as a selectable marker for the screening process.

Genetic modification

3. Type of genetic modification:
Insertion;

In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:
The genes introduced in 59122 maize are maize-optimized cry34Ab1 and cry35Ab1 genes from Bacillus thuringiensis strain PS149B1, providing resistance to certain Coleopteran insects and a plant-optimized pat gene from Streptomyces viridochromogenes, introduced as a selectable marker, providing tolerance to glufosinate herbicide, along with the regulatory components necessary to drive their expression:
- the cry34Ab1 gene, the UBIZM1(2) promoter, the PINII terminator.
- the cry35Ab1 gene, the Peroxidase promoter, the PINII terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.


6. Brief description of the method used for the genetic modification:
59122 maize was genetically modified using Agrobacterium transformation method.

7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:
Not applicable.

Experimental Release

1. Purpose of the release:
The purpose of the release is to refine knowledge concerning the behavior in the environment and the agronomic performances of 59122 maize varieties.

2. Geographical location of the site:
The release is planned at the following location in Spain in 2010:
• Cataluña: Alcarrás (Lérida).


3. Size of the site (m2):
The site could have up to 5000 m² sown with the genetically modified 59122 maize subject of this notification.

4. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:
Many field trials have already been conducted at several locations since 2001 and no environmental problems were reported for these trials. The transgenic plants behaved as conventional maize, except for showing resistance to certain Coleopteran insects, such as the Western corn rootworm, and showing tolerance when glufosinate was applied, traits due to the genetic modification.
59122 maize has been approved for commercial cultivation in the USA and Canada in 2005, Japan in 2006. It is widely cultivated and no adverse effects have been reported to our knowledge.


Environmental Impact and Risk Management

Summary of the potential environmental impact from the release of the GMPts:
No risks to human and animal health or the environment from the deliberate release of genetically modified maize resistant to certain Coleopteran insects and tolerant to glufosinate herbicide are expected, as per information contained in the environmental risk assessment included in the notification.

Brief description of any measures taken for the management of risks:
The pollen shed from the genetically modified plants will be controlled by maintaining a 200-meter isolation distance with any other commercial maize crop. As it is done for any trial with conventional maize, the trial site will be surrounded by agronomic border rows of conventional maize of a similar maturity. The agronomic border rows will be also destroyed at the end of the release.
Grains are fixed on a cob and enclosed in many husks that protect the seeds from outside contact. Thus seed dispersal of individual kernels is not likely to occur. When a few seeds need to be collected for analysis, it will be done by sampling the whole ear and unused seeds will be destroyed.
If needed, the trial could be stopped by mechanical destruction or application of a herbicide other than glufosinate-ammonium, and incorporation into the soil by a deep ploughing.
At the end of the release, all remaining plant matter that has not been harvested for analyses will be destroyed by chopping and incorporating into the soil by a deep ploughing. No plant or plant product coming from the trials will enter the food or feed chains.
After the release, the plot will be visited regularly during the following year in order to ensure removal of maize volunteers, if any. Although volunteer maize cannot generally survive hard winter, maize volunteers, if any, will be monitored in order to ensure their destruction prior to flowering.
No commercial maize crop will be planted on the same plot the following year.


Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:
A trial is planed to refine knowledge on the impact of the cultivation of this maize on key non-target arthropod populations.

Final report


European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
23/03/2010 00:00:00
Remarks:
The competent authority for give the consent of these field trials is the Autonomous Community of Cataluña.